Here are some of the DCI physicians, physician-scientists, researchers & nurses whose work has recently been featured by the media, academic trade publications & journals.
The authors, including corresponding author Madan Kwatra, MD, report that osimertinib inhibits the constitutive activity of EGFRv III tyrosine kinase with high potency.
In July NCATS announced nearly $3 million to fund cooperative agreements with four academic research groups to conduct pre-clinical validation studies...